Director Shareholding

GlaxoSmithKline PLC 27 June 2005 Director's Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 20 June 2005 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 27 June 2005 that 2,495 Ordinary shares in the Company had been sold on behalf of a participant in the GlaxoSmithKline Bonus Investment Plan at a price of £13.3035 per share. The Administrators of the Trust also notified the Company on 27 June 2005 that 3,535 Ordinary shares had been transferred from the Trust to a participant in the GlaxoSmithKline Bonus Investment Plan. 20 June 2005 The Administrators of the Trust also notified the Company on 27 June 2005 that 2,958 Ordinary shares in the Company had been sold on behalf of a participant in the GlaxoSmithKline Annual Investment Plan at a price of £13.3035 per share. The Trust also notified the Company on 27 June 2005 that 4,193 Ordinary shares had been transferred from the Trust to participants in the GlaxoSmithKline Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. One of the Company's directors, Mr J S Heslop is therefore interested in the shares held in the fund from time to time in the same way as other non US employees or former employees of GlaxoSmithKline plc and its subsidiaries. S M Bicknell Company Secretary 27 June 2005 This information is provided by RNS The company news service from the London Stock Exchange END RDSFRMFTMMTTBMA

Companies

GSK (GSK)
UK 100

Latest directors dealings